Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats
- 10 February 2005
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 374 (2), 119-123
- https://doi.org/10.1016/j.neulet.2004.10.036
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The effect of acamprosate on the development of morphineinduced behavioral sensitization in ratsBehavioural Pharmacology, 2003
- The anti‐relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphineBritish Journal of Pharmacology, 2003
- Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine (‘Ecstasy’) and 3,4-methylenedioxy-ethylamphetamine (‘Eve’) measured by conditioned place preference in ratsNeuroscience Letters, 2002
- The development of a conditioned place preference to morphine: Effects of microinjections into various CNS sites.Behavioral Neuroscience, 1997
- Effect of social isolation on the reinforcing properties of morphine in the conditioned place preference testPharmacology Biochemistry and Behavior, 1996
- Isolation rearing prevents the reinforcing properties of amphetamine in a conditioned place preference paradigmEuropean Journal of Pharmacology, 1995
- Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in miceEuropean Journal of Pharmacology, 1993
- Single-trial conditioned place preference using intravenous morphinePharmacology Biochemistry and Behavior, 1986
- Isolation versus grouped housing in rats: Differential effects of low doses of heroin in the place preference paradigmLife Sciences, 1983
- Drug reinforcement studied by the use of place conditioning in ratBrain Research, 1982